title: L-Dopa and the albino riddle: content of L-Dopa in the developing retina of pigmented and albino mice.
abstract: BACKGROUND
  The absence or deficiency of melanin as in albinos, has detrimental effects on retinal development that include aberrant axonal projections from eye to brain and impaired vision. In pigmented retinal pigment epithelium (RPE), dihydroxyphenalanine (L-Dopa), an intermediate in the synthetic path for melanin, has been hypothesized to regulate the tempo of neurogenesis. The time course of expression of retinal L-Dopa, whether it is harbored exclusively in the RPE, the extent of deficiency in albinos compared to isogenic controls, and whether L-Dopa can be restored if exogenously delivered to the albino have been unknown.
  
  
  RESULTS
  L-Dopa and catecholamines including dopamine extracted from retinas of pigmented (C57BL/6J) and congenic albino (C57BL/6J-tyr(c2j) ) mice, were measured throughout development beginning at E10.5 and at maturity. L-Dopa, but not dopamine nor any other catecholamine, appears in pigmented retina as soon as tyrosinase is expressed in RPE at E10.5. In pigmented retina, L-Dopa content increases throughout pre- and postnatal development until the end of the first postnatal month after which it declines sharply. This time course reflects the onset and completion of retinal development. L-Dopa is absent from embryonic albino retina and is greatly reduced in postnatal albino retina compared to pigmented retina. Dopamine is undetectable in both albino and pigmented retinas until after the postnatal expression of the neuronal enzyme tyrosine hydroxylase. If provided to pregnant albino mothers, L-Dopa accumulates in the RPE of the fetuses.
  
  
  CONCLUSIONS
  L-Dopa in pigmented RPE is most abundant during development after which content declines. This L-Dopa is not converted to dopamine. L-Dopa is absent or at low levels in albino retina and can be restored to the RPE by administration in utero. These findings further implicate L-Dopa as a factor in the RPE that could influence development, and demonstrate that administration of L-Dopa could be a means to rescue developmental abnormalities characteristic of albinos.
authors.affiliation: Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, United States of America. Suzanne.Tarlov@tufts.edu
authors.forename: Suzanne
authors.initials: S
authors.lastname: Roffler-Tarlov
authors.forename: Jin Hong
authors.initials: JH
authors.lastname: Liu
authors.forename: Elena N
authors.initials: EN
authors.lastname: Naumova
authors.forename: Maria Margarita
authors.initials: MM
authors.lastname: Bernal-Ayala
authors.forename: Carol A
authors.initials: CA
authors.lastname: Mason
mesh_terms: D000417:Albinism / Q000196:embryology* / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D004298:Dopamine / Q000378:metabolism; D005260:Female; D007980:Levodopa / Q000008:administration & dosage / Q000378:metabolism*; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D014442:Monophenol Monooxygenase / Q000235:genetics / Q000378:metabolism; D055495:Neurogenesis; D011247:Pregnancy; D012160:Retina / Q000187:drug effects / Q000196:embryology* / Q000378:metabolism*; D055213:Retinal Pigment Epithelium / Q000378:metabolism
chemical_list: D007980:Levodopa; D014442:Monophenol Monooxygenase; D004298:Dopamine